Spectrum of candidal species isolated from neonates admitted in an Intensive Care Unit of teaching hospital of Kashmir, North India

Asifa Nazir; Talat Masoodi

doi:10.4103/JLP.JLP_1_18

Journal of Laboratory Physicians, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · J Lab Physicians 2018; 10(03): 255-259
DOI: 10.4103/JLP.JLP_1_18

Original Article

Spectrum of candidal species isolated from neonates admitted in an Intensive Care Unit of teaching hospital of Kashmir, North India

Autor*innen

Asifa Nazir

Department of Microbiology, Government Medical College, Srinagar, Jammu and Kashmir, India
Talat Masoodi

Department of Microbiology, SKIMS Medical College, Srinagar, Jammu and Kashmir, India

Abstract

als PDF herunterladen

ABSTRACT

BACKGROUND: Candidal infections are an important cause of morbidity and mortality in Neonatal Intensive Care Unit. Neonatal candidiasis is increasing in frequency, mainly because of increase in the survival of babies with low-birth weight, preterm births, advancement in medical field, life support systems, relative immunodeficiency, and extensive use of broad-spectrum antibiotics. Over the past few decades, there has been a progressive shift from the predominance of Candida albicans to nonalbicans Candida species.

AIMS AND OBJECTIVES: The objective of the current study was to know the prevalence of nonalbicans candidemia in neonates and their antifungal susceptibility pattern.

Materials and Methods: In this study, a total of 424 samples from clinically diagnosed septicemic neonates were included. Identification of Candida isolates from these samples as well as their antifungal sensitivity testing was performed with Vitek 2 Compact (Biomerieux France) using Vitek 2 cards for identification of yeast and yeast-like organisms (ID-YST cards).

Results: A total of 246/424 (58.01%) cases were blood culture positive. Out of these, 80/246 samples tested positive for candidemia (32.5%). Candida tropicalis (13.8%) was the predominant species isolated among the non-albicans Candida followed by Candida krusei (4.8%), Candida parapsilosis (3.2%), Candida guilliermondii (2.8%), and Candida dubliniensis (2.0%). We found an increase in the antifungal drug resistance, especially for the azole group of drugs, both in C. albicans and non-albicans Candida species. All the isolates were uniformly sensitive to micafungin, voriconazole, and caspofungin.

Conclusions: Candidemia in neonates is an ominous prognostic sign and is an important entity in our region. The present study highlights the mycological shift of Candida species in neonatal candidemia with a preponderance of nonalbicans Candida species.

Keywords

Antifungal susceptibility - Candida albicans - neonatal candidaemia - non-albicans candida

PDF (438 kb)

Referenzen

References
1 Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 1991;91:86S-9S.
2 Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995;20:1526-30.
3 Tritipwanit K, Chindamporn A, Suankratay C. Epidemiology of candidaemia at King Chulalongkorn Memorial Hospital, Thailand. J Infect Dis Antimicrob Agents 2005;22:59-69.
4 Sahni V, Agarwal SK, Singh NP, Anuradha S, Sikdar S, Wadhwa A, et al. Candidemia – An under-recognized nosocomial infection in Indian hospitals. J Assoc Physicians India 2005;53:607-11.
5 Narang A, Agrawal PB, Chakrabarti A, Kumar P. Epidemiology of systemic candidiasis in a tertiary care neonatal unit. J Trop Pediatr 1998;44:104-8.
6 Baradkar VP, Mathur M, Kumar S, Rathi M. Candida glabrata emerging pathogen in neonatal sepsis. Ann Trop Med Public Health 2008;1:5-8.
7 Pfaller MA. Epidemiology of candidiasis. J Hosp Infect 1995;30 Suppl:329-38.
8 Chakrabarty A, Singh K, Das S. Changing face of nosocomial candidaemia. Indian J Med Microbiol 1999;17:160-6.
9 Wenzel RP. Nosocomial candidemia: Risk factors and attributable mortality. Clin Infect Dis 1995;20:1531-4.
10 Agarwal J, Bansal S, Malik GK, Jain A. Trends in neonatal septicemia: Emergence of non-albicans Candida. Indian Pediatr 2004;41:712-5.
11 McGinnis MR. Yeast identification. In: Laboratory Handbook of Medical Mycology. New York: Academic Press; 1980. p. 337-73.
12 Carvalho PR, Feldens L, Seitz EE, Rocha TS, Soledade MA, Trotta EA, et al. Prevalence of systemic inflammatory syndromes at a tertiary pediatric Intensive Care Unit. J Pediatr (Rio J) 2005;81:143-8.
13 Baley JE, Kliegman RM, Fanaroff AA. Disseminated fungal infections in very low-birth-weight infants: Clinical manifestations and epidemiology. Pediatrics 1984;73:144-52.
14 Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of North India: 5-year study. Infection 2007;35:256-9.
15 Kapila S. Indentification of Candida species in neonatal septicemia. Int J Contemp Pediatr 2016;3:601-5.
16 Mendiratta DK, Rawat V, Thamke D, Chaturvedi P, Chhabra S, Narang P, et al. Candida colonization in preterm babies admitted to neonatal Intensive Care Unit in the rural setting. Indian J Med Microbiol 2006;24:263-7.
17 Pfaller MA, Diekema DJ, Rinaldi MG, Barnes R, Hu B, Veselov AV, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: A 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol 2005;43:5848-59.
18 Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J, et al. Risk factors for candidemia in neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey Study Group. Pediatr Infect Dis J 2000;19:319-24.
19 Shivaprakasha S, Radhakrishnan K, Karim PM. Candida spp. Other than Candida albicans: A major cause of fungaemia in a tertiary care centre. Indian J Med Microbiol 2007;25:405-7.
20 Verma AK, Prasad KN, Singh M, Dixit AK, Ayyagari A. Candidaemia in patients of a tertiary health care hospital from North India. Indian J Med Res 2003;117:122-8.
21 Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC, et al. Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992;15:414-21.
22 Gupta N, Mittal N, Sood P, Kumar S, Kaur R, Mathur MD, et al. Candidemia in neonatal Intensive Care Unit. Indian J Pathol Microbiol 2001;44:45-8.
23 Singh K, Chakrabarti A, Narang A, Gopalan S. Yeast colonisation & fungaemia in preterm neonates in a tertiary care centre. Indian J Med Res 1999;110:169-73.
24 Rani R, Mohapatra NP, Mehta G, Randhawa VS. Changing trends of Candida species in neonatal septicaemia in a tertiary North Indian hospital. Indian J Med Microbiol 2002;20:42-4.
25 Goel N, Ranjan PK, Aggarwal R, Chaudhary U, Sanjeev N. Emergence of non albicans Candida in neonatal septicemia and antifungal susceptibility: Experience from a tertiary care center. J Lab Physicians 2009;1:53-5.
26 Narain S, Shastri JS, Mathur M, Mehta PR. Neonatal systemic candidiasis in a tertiary care centre. Indian J Med Microbiol 2003;21:56-8.
27 Kothari A, Sagar V. Epidemiology of Candida bloodstream infections in a tertiary care institute in India. Indian J Med Microbiol 2009;27:171-2.
28 Bhatt M, Sarangi G, Paty BP, Mohapatra D, Chayani N, Mahapatra A, et al. Biofilm as a virulence marker in Candida species in nosocomial blood stream infection and its correlation with antifungal resistance. Indian J Med Microbiol 2015;33, Suppl S1:112-4.
29 Pahwa N, Kumar R, Nirkhiwale S, Bandi A. Species distribution and drug susceptibility of Candida in clinical isolates from a tertiary care centre at Indore. Indian J Med Microbiol 2014;32:44-8.